Nurse Practitioner Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Bridget Gresback

Nurse Practitioner, Pediatrics Huntsville, AL Nurse Practitioner

NPI 1831786714 CMS profile 11054282

2317 Memorial Pkwy Sw Ste 410, Huntsville, AL 35801

Open in the dashboard

General payments

$841

23 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Bridget Gresback of Huntsville, AL is reported in the CMS Open Payments database as having received $841 across 23 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $68 3
2022 General $297 16
2021 General $477 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bridget Gresback
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Bridget Gresback were reported at $0. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Bridget Gresback Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $477 $60 $23–$142 $132
2022 $297 $72 $27–$161 $149
2023 $68 $89 $35–$185 $160
2024 $0 $93 $34–$199 $164
2025 $0 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. Astellas Pharma US Inc $212 11 payments
  2. Janssen Biotech, Inc. $124 1 payment
  3. Bayer HealthCare Pharmaceuticals Inc. $123 1 payment
  4. Urogen Pharma, Inc. $121 1 payment
  5. Myovant Sciences Inc. $108 1 payment
  6. Urovant Sciences Inc $94 5 payments
  7. Boston Scientific Corporation $31 1 payment
  8. Axonics Modulation Technologies, Inc. $15 1 payment
  9. Sumitomo Pharma America, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Food and Beverage $779 22 payments
  2. Education $62 1 payment
Products named General payments · program years 2021–2023
  1. MYRBETRIQ $150 10 payments
  2. ERLEADA $124 1 payment
  3. Nubeqa $123 1 payment
  4. JELMYTO $121 1 payment
  5. ORGOVYX $108 1 payment
  6. GEMTESA $106 6 payments
  7. Axonics $15 1 payment
  8. Bulkamid $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

27

Median for Nurse Practitioner: 389

Drug cost

$13,651

Median for Nurse Practitioner: $21,885

Branded share of claims

59.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 16 $13,258
Trospium Chloride Generic 11 $393

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$2,508

Medicare's payments for the services billed

Medicare patients

33

Average age 64

Services billed

45

15 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Depression 45%
Arthritis 42%
Diabetes 33%
Chronic kidney disease 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Pediatrics in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record